Study 45 – Randomized, Double-Blind, Placebo-Controlled Trial of Monthly Injectable Buprenorphine for Methamphetamine Use Disorder (MURB); CTN-0110

Principal Investigators: Steve Shoptaw, Ph.D. (University of California, Los Angeles), Madhukar H. Trivedi, M.D. (University of Texas Southwestern Medical Center) Site Investigators: Erik Anderson, M.D., Andrew Herring, M.D. (Alameda Health System), Tara Chowdhury, Ph.D. (COGA, Inc.), Julie Croff, Ph.D., MPH, FAAHB (Oklahoma State University), Sidarth Wakhlu, M.D. (University of Texas Southwestern Medical Center), Judith Tsui, … Continue reading Study 45 – Randomized, Double-Blind, Placebo-Controlled Trial of Monthly Injectable Buprenorphine for Methamphetamine Use Disorder (MURB); CTN-0110